Skip to content
HeyJared

Arthritis Rheumatol

Reporter · US

Indexed articles, last 90 days
3
Latest publication
Sep 15, 2026
Outlet visibility, for Medscape
Top 50K sites
Earliest in this view
Aug 25, 2026

Latest articles

  1. Article · Sep 15, 2026 · Arthritis Rheumatol. 2026;

    SLE Incidence Appears to Peak Later in Men Than in Women (opens the original)

    Excerpt · English

    Read excerpt

    In a meta-analysis, the incidence of systemic lupus erythematosus (SLE) peaked among women in their 30s and among men in their 60s. Other notable age-, sex-, and ethnicity-specific patterns were also reported. "The identification of a later peak in age at diagnosis among men, together with the substantial burden of late diagnosis of SLE overall, highlights the need to consider age and sex jointly in epidemiologic studies and clinical evaluation of SLE," the authors of the study wrote. The study

  2. Article · Sep 4, 2026 · Arthritis Rheumatol. 2026;

    Avacopan in Vasculitis: Uncommon but Severe Liver Risks (opens the original)

    Excerpt · English

    Read excerpt

    Among patients treated with avacopan, which is approved for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, liver enzyme elevations were uncommon overall, but two patients developed severe drug-induced liver injury that resolved after the drug was discontinued. "Avacopan represents an important therapeutic option for patients with AAV [ANCA-associated vasculitis]; however, these risks should be thoroughly discussed with patients, and routine monitoring timelines, particularly i

  3. Article · Aug 25, 2026 · Arthritis Rheumatol. 2026;

    Longer Targeted Therapy May Not Raise Cancer Risk in SpA (opens the original)

    Excerpt · English

    Read excerpt

    Patients with spondyloarthritis (SpA) exposed to targeted therapy for more than 6 months per year did not have a higher overall risk for cancer compared with those exposed to targeted therapy for 6 months or less. "Although the observational design of this study precludes any causal inference and residual confounding (such as tobacco or alcohol use or disease activity) cannot be fully excluded, these findings provide reassuring evidence regarding the long-term safety of targeted therapy in terms

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 50K sites

For Medscape, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Arthritis Rheumatol